CELESTE KEGLEY: Open Payments
NPI 1477233252 · UTICA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$924 in 50 payments from 10 companies in 2025. Trend: 2023 $139 · 2024 $628 · 2025 $924
Food & beverage: $924
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $254 |
| Novartis Pharmaceuticals Corporation | 14 | $180 |
| PFIZER INC. | 5 | $95 |
| SCPHARMACEUTICALS INC. | 4 | $78 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $67 |
| Alnylam Pharmaceuticals Inc. | 3 | $67 |
| Amgen Inc. | 4 | $59 |
| AstraZeneca Pharmaceuticals LP | 3 | $54 |
| Merck Sharp & Dohme LLC | 2 | $46 |
| Esperion Therapeutics, Inc. | 1 | $23 |
Products named: JARDIANCE, LEQVIO, ELIQUIS, FUROSCIX, Kerendia, ONPATTRO, REPATHA, WAINUA.
Industry payments across NY — which companies pay providers there.
